Jaguar Health Inc. enters Manufacturing and Supply Agreement

Napo Pharmaceuticals Inc., a wholly-owned subsidiary of Jaguar Health, entered into a Manufacturing and Supply Agreement with Alivus Life Sciences. This deal secures the supply of Crofelemer, the active ingredient in Mytesi, ensuring continued production capabilities for the company's flagship drug.